Inhibitor to Factor VIII in Mild Haemophilia
1984 ◽
Vol 52
(01)
◽
pp. 050-052
◽
SummaryFactor VIII inhibitors in mild haemophilia are uncommon and the management of such patients is controversial. The development of a persistently high responding F VIII inhibitor in a mild haemophiliac is reported and the behaviour of the inhibitor discussed in the context of the various therapeutic regimes employed for symptomatic management. When inhibitor titres were low, endogenous F VIII stimulation, by DDAVP, was less immunogenic than the administration of exogenous F VIII concentrates. This inhibitor displayed characteristics of an autoantibody, and was characterised as an immunoglobulin of IgG subtype.
2002 ◽
Vol 117
(1)
◽
pp. 136-140
◽
Keyword(s):
1986 ◽
Vol 62
(4)
◽
pp. 786-787
◽
Keyword(s):
1976 ◽
Vol 35
(03)
◽
pp. 510-521
◽
Keyword(s):
1981 ◽
Vol 45
(03)
◽
pp. 285-289
◽
Keyword(s):
1993 ◽
Vol 69
(02)
◽
pp. 115-118
◽
1979 ◽
Vol 42
(05)
◽
pp. 1355-1367
◽
Keyword(s):